JPS61153568A - 免疫螢光分析のための螢光抗体 - Google Patents
免疫螢光分析のための螢光抗体Info
- Publication number
- JPS61153568A JPS61153568A JP18498885A JP18498885A JPS61153568A JP S61153568 A JPS61153568 A JP S61153568A JP 18498885 A JP18498885 A JP 18498885A JP 18498885 A JP18498885 A JP 18498885A JP S61153568 A JPS61153568 A JP S61153568A
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- fluorescent
- rare earth
- item
- binding
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000004458 analytical method Methods 0.000 title description 4
- 102000036639 antigens Human genes 0.000 claims description 45
- 108091007433 antigens Proteins 0.000 claims description 45
- 239000000427 antigen Substances 0.000 claims description 44
- 238000000034 method Methods 0.000 claims description 40
- 229910052761 rare earth metal Inorganic materials 0.000 claims description 27
- 239000003446 ligand Substances 0.000 claims description 22
- 239000000126 substance Substances 0.000 claims description 16
- 239000013076 target substance Substances 0.000 claims description 15
- -1 rare earth ion Chemical class 0.000 claims description 14
- 239000013522 chelant Substances 0.000 claims description 13
- 150000002910 rare earth metals Chemical class 0.000 claims description 13
- 230000027455 binding Effects 0.000 claims description 10
- 238000001514 detection method Methods 0.000 claims description 8
- 230000005855 radiation Effects 0.000 claims description 7
- POILWHVDKZOXJZ-ARJAWSKDSA-M (z)-4-oxopent-2-en-2-olate Chemical compound C\C([O-])=C\C(C)=O POILWHVDKZOXJZ-ARJAWSKDSA-M 0.000 claims description 5
- 238000002372 labelling Methods 0.000 claims description 4
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims 4
- 239000007850 fluorescent dye Substances 0.000 description 19
- 239000000758 substrate Substances 0.000 description 19
- 230000005284 excitation Effects 0.000 description 16
- 239000007787 solid Substances 0.000 description 14
- 150000001875 compounds Chemical class 0.000 description 11
- 239000000243 solution Substances 0.000 description 7
- 239000000463 material Substances 0.000 description 6
- 230000035945 sensitivity Effects 0.000 description 6
- 238000009826 distribution Methods 0.000 description 5
- 238000004020 luminiscence type Methods 0.000 description 5
- AJMSJNPWXJCWOK-UHFFFAOYSA-N pyren-1-yl butanoate Chemical compound C1=C2C(OC(=O)CCC)=CC=C(C=C3)C2=C2C3=CC=CC2=C1 AJMSJNPWXJCWOK-UHFFFAOYSA-N 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 239000000975 dye Substances 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 238000003127 radioimmunoassay Methods 0.000 description 4
- 238000012546 transfer Methods 0.000 description 4
- 229910052693 Europium Inorganic materials 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 230000008878 coupling Effects 0.000 description 3
- 238000010168 coupling process Methods 0.000 description 3
- 238000005859 coupling reaction Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000000295 emission spectrum Methods 0.000 description 3
- 238000001506 fluorescence spectroscopy Methods 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- VSHPLUBHIUFLES-UHFFFAOYSA-N 5-acetylthiophene-2-carbonitrile Chemical compound CC(=O)C1=CC=C(C#N)S1 VSHPLUBHIUFLES-UHFFFAOYSA-N 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- 150000001450 anions Chemical class 0.000 description 2
- 230000021615 conjugation Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- OGPBJKLSAFTDLK-UHFFFAOYSA-N europium atom Chemical compound [Eu] OGPBJKLSAFTDLK-UHFFFAOYSA-N 0.000 description 2
- 238000000695 excitation spectrum Methods 0.000 description 2
- 238000010265 fast atom bombardment Methods 0.000 description 2
- 238000001917 fluorescence detection Methods 0.000 description 2
- 238000000799 fluorescence microscopy Methods 0.000 description 2
- 238000001215 fluorescent labelling Methods 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 238000003018 immunoassay Methods 0.000 description 2
- 238000010185 immunofluorescence analysis Methods 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000002285 radioactive effect Effects 0.000 description 2
- 230000003595 spectral effect Effects 0.000 description 2
- 239000013077 target material Substances 0.000 description 2
- XBUCSKKBSJSRLJ-UHFFFAOYSA-N 1-(5-iodothiophen-2-yl)ethanone Chemical compound CC(=O)C1=CC=C(I)S1 XBUCSKKBSJSRLJ-UHFFFAOYSA-N 0.000 description 1
- KBGRHHZNPOCLKT-UHFFFAOYSA-N 1-[5-(aminomethyl)thiophen-2-yl]ethanone Chemical compound CC(=O)C1=CC=C(CN)S1 KBGRHHZNPOCLKT-UHFFFAOYSA-N 0.000 description 1
- 238000003512 Claisen condensation reaction Methods 0.000 description 1
- XUIIKFGFIJCVMT-GFCCVEGCSA-N D-thyroxine Chemical compound IC1=CC(C[C@@H](N)C(O)=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-GFCCVEGCSA-N 0.000 description 1
- XPDXVDYUQZHFPV-UHFFFAOYSA-N Dansyl Chloride Chemical compound C1=CC=C2C(N(C)C)=CC=CC2=C1S(Cl)(=O)=O XPDXVDYUQZHFPV-UHFFFAOYSA-N 0.000 description 1
- LTMHDMANZUZIPE-AMTYYWEZSA-N Digoxin Natural products O([C@H]1[C@H](C)O[C@H](O[C@@H]2C[C@@H]3[C@@](C)([C@@H]4[C@H]([C@]5(O)[C@](C)([C@H](O)C4)[C@H](C4=CC(=O)OC4)CC5)CC3)CC2)C[C@@H]1O)[C@H]1O[C@H](C)[C@@H](O[C@H]2O[C@@H](C)[C@H](O)[C@@H](O)C2)[C@@H](O)C1 LTMHDMANZUZIPE-AMTYYWEZSA-N 0.000 description 1
- 102100027285 Fanconi anemia group B protein Human genes 0.000 description 1
- 101000914679 Homo sapiens Fanconi anemia group B protein Proteins 0.000 description 1
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 102100028255 Renin Human genes 0.000 description 1
- 108090000783 Renin Proteins 0.000 description 1
- 229910052771 Terbium Inorganic materials 0.000 description 1
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical group C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 125000004202 aminomethyl group Chemical group [H]N([H])C([H])([H])* 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 125000003636 chemical group Chemical group 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 230000001268 conjugating effect Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- LTMHDMANZUZIPE-PUGKRICDSA-N digoxin Chemical compound C1[C@H](O)[C@H](O)[C@@H](C)O[C@H]1O[C@@H]1[C@@H](C)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@@H]3C[C@@H]4[C@]([C@@H]5[C@H]([C@]6(CC[C@@H]([C@@]6(C)[C@H](O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)C[C@@H]2O)C)C[C@@H]1O LTMHDMANZUZIPE-PUGKRICDSA-N 0.000 description 1
- 229960005156 digoxin Drugs 0.000 description 1
- LTMHDMANZUZIPE-UHFFFAOYSA-N digoxine Natural products C1C(O)C(O)C(C)OC1OC1C(C)OC(OC2C(OC(OC3CC4C(C5C(C6(CCC(C6(C)C(O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)CC2O)C)CC1O LTMHDMANZUZIPE-UHFFFAOYSA-N 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000005281 excited state Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000002795 fluorescence method Methods 0.000 description 1
- 238000005558 fluorometry Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 229940127121 immunoconjugate Drugs 0.000 description 1
- 238000010166 immunofluorescence Methods 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 239000012948 isocyanate Substances 0.000 description 1
- 150000002513 isocyanates Chemical class 0.000 description 1
- 150000002540 isothiocyanates Chemical class 0.000 description 1
- 239000006193 liquid solution Substances 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229960000485 methotrexate Drugs 0.000 description 1
- 150000002894 organic compounds Chemical group 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 239000012857 radioactive material Substances 0.000 description 1
- 239000000700 radioactive tracer Substances 0.000 description 1
- 239000002901 radioactive waste Substances 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 238000010183 spectrum analysis Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- GZCRRIHWUXGPOV-UHFFFAOYSA-N terbium atom Chemical compound [Tb] GZCRRIHWUXGPOV-UHFFFAOYSA-N 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229940034208 thyroxine Drugs 0.000 description 1
- XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Landscapes
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/591,305 US4058732A (en) | 1975-06-30 | 1975-06-30 | Method and apparatus for improved analytical fluorescent spectroscopy |
| US591305 | 1990-10-01 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS61153568A true JPS61153568A (ja) | 1986-07-12 |
| JPS6218868B2 JPS6218868B2 (enExample) | 1987-04-24 |
Family
ID=24365955
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP18498885A Granted JPS61153568A (ja) | 1975-06-30 | 1985-08-21 | 免疫螢光分析のための螢光抗体 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS61153568A (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH06148076A (ja) * | 1992-11-10 | 1994-05-27 | Hamamatsu Photonics Kk | 核酸の塩基配列決定方法、単一分子検出方法、その装置及び試料の作成方法 |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11614445B2 (en) * | 2016-06-09 | 2023-03-28 | Radiometer Turku Oy | Background blockers for binding assays |
-
1985
- 1985-08-21 JP JP18498885A patent/JPS61153568A/ja active Granted
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH06148076A (ja) * | 1992-11-10 | 1994-05-27 | Hamamatsu Photonics Kk | 核酸の塩基配列決定方法、単一分子検出方法、その装置及び試料の作成方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6218868B2 (enExample) | 1987-04-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1082106A (en) | Method, apparatus, and compositions for analytical fluorescent spectroscopy and immunofluorometric assay | |
| US4341957A (en) | Fluorescent antibody composition for immunofluorometric assay | |
| US4923819A (en) | Time-resolved fluorescence immunoassay | |
| US4666862A (en) | Fluorescent energy transfer with phycobiliproteins | |
| Elbanowski et al. | The lanthanides as luminescent probes in investigations of biochemical systems | |
| CA1248445A (en) | Fluorescent labels and labeled species and their use in analytical elements and determinations | |
| Youn et al. | Fluorescence energy transfer immunoassay based on a long-lifetime luminescent metal–ligand complex | |
| US9594078B2 (en) | Chromatographic assay system | |
| US5464741A (en) | Palladium (II) octaethylporphine alpha-isothiocyanate as a phosphorescent label for immunoassays | |
| US4222744A (en) | Assay for ligands | |
| US4222743A (en) | Method and apparatus for detecting biological particles by fluorescent stain | |
| JPH06500852A (ja) | 螢光化合物からの発光信号増幅方法 | |
| EP1684808A1 (en) | A reagent system and method for modifying the luminescence of lanthanide(iii) macrocyclic complexes | |
| GB2065298A (en) | Method and Apparatus for Detecting Biological Particles by Induced Signal | |
| FI87022C (fi) | Maerkta och maerkningsbara reagenser foer fluorometriska bestaemningar | |
| EP0632893A1 (en) | Fluorescence immunoassays using fluorescent dyes free of aggregation and serum binding | |
| GB2326712A (en) | Colour developing process involving and enzyme, and a substrate therefor comprising an indolyl derivative | |
| JPS61153568A (ja) | 免疫螢光分析のための螢光抗体 | |
| RU2009505C1 (ru) | Способ люминесцентного иммуноанализа | |
| Lakowicz et al. | Fluorescence lifetime energy-transfer immunoassay quantified by phase-modulation fluorometry | |
| Adeyiga et al. | Advances in the development of lanthanide macrocyclic complexes as luminescent biomarkers | |
| US20020187563A1 (en) | Diagnostic neodymium(iii), ytterbium(iii), or erbium(iii) ion-ligand complexes | |
| JPH10332695A (ja) | 核酸，蛋白質等の検出方法 | |
| CN118480059A (zh) | Tadf-稀土配合物体系、纳米微球、稀土发光试剂、其制备方法和应用 | |
| Soini | The principle of time-resolved fluorometry |